Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.
Structural heart diseaseValvular Aortic valveMitral valve

TCT 2017 | MAVERIC: Results 6 Months After Transcatheter Mitral Valve Replacement

solaci
solaci
586
0

 Courtesy of the SBHCI.

This seems to be the year for transcatheter mitral valve devices, and the ARTO system tested in this study looks promising for the treatment of patients with severe mitral regurgitation who are symptomatic due to heart failure and ejection fraction <40%.

TCT 2017 | MAVERIC: resultados a 6 meses del reemplazo mitral por catéter

The study enrolled 50 patients who underwent clinical and ecocardiographic follow-up at 1 month, 6 months, 1 year, 2 years, and up to 3 years.

Read also: “ABSORB III: after 3 Years, the Bioresorbable Scaffold is Still a Disappointment”.

The rate of adverse events at 6 months was 16% (among these, there were 3 deaths that were not procedure-related). There was a significant improvement in mitral regurgitation, with reduction of regurgitation volume, annular diameter, and end-diastolic volume.

 

The MAVERIC study showed that the ARTO system is safe and effective for the treatment of functional mitral regurgitation.

 

Courtesy of the SBHCI.

 

Original title: 6-Month Outcomes of Transcatheter MV Repair in Patients With Severe Secondary Mitral Regurgitation.

Presenter: Stephen G. Worthley.

 

MAVERIC

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

Previous article
ABSORB III: after 3 Years, the Bioresorbable Scaffold is Still a Disappointment
Next article
TCT 2017 | INTREPID: Mitral Replacement with a Self-Expanding Device
solaci
solaci

More articles by this author

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Dr. Juan Manuel Pérez - 0
Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Dr. Omar Tupayachi - 0
Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Dr. Juan Manuel Pérez - 0
Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

Dr. Juan Manuel Pérez - 0
TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Mitral valve

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and...
Dr. Juan Manuel Pérez -
SOLACI Sessionsspot_img

Recent Articles

Complex radial access: a four-step protocol to overcome loops and tortuosity

Dr. Juan Manuel Pérez - 0
Radial access is currently the preferred strategy for coronary angiography and percutaneous coronary interventions due to its lower rates of bleeding and vascular complications...

Percutaneous closure of paravalvular leaks in high-risk patients: clinical outcomes and the impact of residual leak

Dr. Juan Manuel Pérez - 0
Paravalvular leak (PVL) is a relatively frequent complication following valve replacement (overall incidence 5–18%; 2–10% in the aortic position and 7–17% in the mitral...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Dr. Omar Tupayachi - 0
Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...